Keystone Clinical Studies: Bipolar Depression

309659-page-001

Has your life been affected by bipolar depression?

If so, you may be interested in taking part in the 401 or 402 Study.

 

The 401 and 402 Studies are looking at a potential new treatment – an investigational medication – for bipolar depression (bipolar I or bipolar II disorder) to see whether it works, and how safe it is, for improving the symptoms of bipolar depression.

The 401 Study will look at the investigational medication when it is used on its own.

The 402 Study will look at the investigational medication in patients who are already taking a mood stabilizer.

We are currently looking for people who experience major depressive episodes associated with bipolar disorder to take part in the 401 and 402 Studies.

You may be able to take part in the 401 or 402 Study if you:

  • are between 18 and 65 years of age (inclusive)
  • have been diagnosed with bipolar I or bipolar II disorder
  • are currently having a major depressive episode that started at least 2 weeks ago, but no more than 6 months ago
  • have previously had at least one bipolar manic episode or mixed episode (if you have bipolar I disorder) or hypomanic episode (if you have bipolar II disorder).

The studies will last up to 12 weeks and will require nine visits to the study center in Norristown, PA.

If you are interested in taking part in one of these studies, or if you would like more

information, please contact:

 

 

Tel: 610 277 8073

www.keystoneclinicalstudies.com